BDBM645537 2-(4-{2-[(4-{[6-(5-chloro-2- fluorophenyl)pyridazin-4-yl]- amino}quinolin-7-yl)oxy]- ethyl}piperazin-1-yl)ethan- 1-ol::US20240018122, Example 72

SMILES OCCN1CCN(CCOc2ccc3c(Nc4cnnc(c4)-c4cc(Cl)ccc4F)ccnc3c2)CC1

InChI Key InChIKey=HWSIPFXXHNTZOG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 645537   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645537(US20240018122, Example 72 | 2-(4-{2-[(4-{[6-(5-chl...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
US Patent